RECLASSIFICATION OF CA CERVIX USING MUCIN STAINS AND ITS CLINICAL RELEVANCE

Similar documents
Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals

Histopathology: Cervical HPV and neoplasia

A Study of significance of mucin histochemistry in histopathological diagnosis of cervical carcinoma

LESION AT PACIFIC MEDICAL COLLEGE, UDAIPUR. 1. Assistant Professor, Department of Pathology, Pacific Medical college and hospital, Udaipur.

Cytology Update M Laing QEUH

WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1

Chapter 8 Adenocarcinoma

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

A study on correlation between bleeding pattern and histopathological findings of endometrium among perimenopausal women

CERVIX. MLS Basic histological diagnosis MLS HIST 422 Semester 8- batch 7 L12 : Dr. Ali Eltayb.

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

Cervical cancer presentation

Fluorescence Spectroscopy: A New Approach in Cervical Cancer

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Lesions of uterine cervix by cytology and histopathology- A prospective study for a period of two years

CERVICAL CANCER FACTSHEET. What is cervical cancer?

AgNOR Count and its Correlation with Colposcopy in Suspicious Cervix

Use of Schiller s test versus Pap smear to increase detection rate of cervical dysplasias

One of the commonest gynecological cancers,especially in white Americans.

VULVAR CARCINOMA. Page 1 of 5

CASE 4 21/07/2017. Ectopic Prostatic Tissue in Cervix. Female 31. LLETZ for borderline nuclear abnormalities

Study of incidence and different aspects of cervical malignancy in tertiary centre of Jharkhand, India

ANALYSES OF CERVICAL CANCER IN RAJKOT POPULATION

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

International Journal of Biological & Medical Research

Mucin Histochemistry Study of the Prostate in Normal and Malignant Lesions

Retrospective evaluation of clinical and pathological features, as well as diagnostic and treatment protocols of primary vaginal malignancy

Estimated New Cancers Cases 2003

Study of Cervical Pap Smears in a Tertiary Hospital

A Study on Diagnostic Accuracy of Cervical Pap Smear by Correlating with Histopathology in a Tertiary Care Centre

What Causes Cervical Cancer? Symptoms of Cervical Cancer

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Role of cytology, colposcopy and colposcopic directed biopsy in the evaluation of unhealthy cervix

A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer

Done by khozama jehad. Neoplasia of the cervix

uterine cancer endometrial cancer

Int. J. Life. Sci. Scienti. Res., 2(3): (ISSN: ) Impact Factor 2.4 MAY Research Article (Open access)

Biomed Environ Sci, 2015; 28(1): 80-84

Can the Ovaries be preserved in Selected Cases of Endometrial Cancer?

Vaginal intraepithelial neoplasia

Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test

What is endometrial cancer?

What is cervical cancer?

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Clinical statistics of gynecologic cancers in Japan

Pancreatobiliary Frozen Section Nightmares

HIV and AIDS Related Cancers DR GORDON AMBAYO UHS

Session Number: 1020 Session: Adenocarcinoma of the Cervix: Diagnostic Pitfalls and New Prognostic Implications. Andres A. Roma, MD Cleveland Clinic

JMSCR Vol 05 Issue 11 Page November 2017

Immunohistochemical Expression of Cytokeratin 5/6 in Gynaecological Tumors.

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

CORRELATION OF PAP SMEAR AND COLPOSCOPIC FINDING OF CERVIX WITH HISTOPATHOLGIOCAL REPORT IN A GROUP OF PATIENT ATTENDING IN A TERTIARY HOSPITAL

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Muco-epidermoid tumours of the anal canal

JMSCR Vol 05 Issue 11 Page November 2017

Understanding Your Pap Test Results

Cancer Cervix with Brain Metastasis- A rare case from a Rural center of Maharashtra

ICD-9-CM to ICD-10-CM DIAGNOSIS CODE MAPPING. Central Valley Public Health: Women's Way

How invasive cervical cancer audit affects clinical practice

Mixed glandular and squamous-cell carcinoma

International Journal of Health Sciences and Research ISSN:

BCCCP Approved ICD-9 Code List Fiscal Year 2010

Gynaecological Malignancies

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

Clinically Microscopically Pathogenesis: autoimmune not lifetime

Abscopal Effect of Radiation on Toruliform Para-aortic Lymph Node Metastases of Advanced Uterine Cervical Carcinoma A Case Report

Utility of Pap Smear in Cervical Screening in a Tertiary Care Hospital

SCAR ENDOMETRIOSIS: CASE REPORT Onimi Syamala 1, G. Usha Rani 2

STUDY OF EARLY DETECTION OF CERVICAL CANCER BY PAP S SMEAR IN SELECTED SETTING OF PUDUCHERRY

Introduction to Colposcopy

Diagnostically Challenging Cases in Gynecologic Pathology

Investigation of 100 consecutive negative cone biopsies

PREVALENCE OF GOBLET CELL METAPLASIA IN ENDOCERVICAL AND ENDOMETRIAL ADENOCARCINOMA : A HISTOCHEMICAL STUDY

Romanian Journal of Morphology and Embryology 2006, 47(1):53 58

Pap Smear and Histopathological Study of Cervical Lesions

Human Papillomavirus and Head and Neck Cancer. Ed Stelow, MD

Case report. Neuroendocrine differentiation in a case of cervical cancer. Open Access. Mona Mohamed Rashed 1, Alemayehu Bekele 2

Incidence of Non-Neoplastic Cervical Pathologies Recorded at a Medical College

Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia

PDF of Trial CTRI Website URL -

Can LBC Completely Replace Conventional Pap Smear in Developing Countries

Histopathological Correlation with Cervical Cytology

HPV Genotyping: A New Dimension in Cervical Cancer Screening Tests

An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia

Making Sense of Cervical Cancer Screening

The society for lower genital tract disorders since 1964.

Page 302. were taken for immunohistochemical expression of HER- of January 2017 to June 2018.Out of 105 cases, 20 cases prognosis).

CPC on Cervical Pathology

Bartholin Gland Carcinomas

Enterprise Interest None

Cervical Cancer : Pap smear

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

American Journal of. Medical Case Reports. CAM5.2 Expression in Metastatic Tumours of CNS: A Diagnostic Tool

Adenoid basal carcinoma of the cervix uteri'

BC Cancer Cervix Screening 2015 Program Results. February 2018

Transcription:

Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 RECLASSIFICATION OF CA CERVIX USING MUCIN STAINS AND ITS CLINICAL RELEVANCE Dr Sudha Gupta 1 *, Dr. Dinesh K.Gupta 2,Dr.Kunal Purohit 3 1. Ex-Professor, Department of Pathology, Mahatma Gandhi Medical College and Hospital, Jaipur 2. Associate professor, Department of Radio diagnosis, RUHS CMS, Jaipur. 3. Resident, Department of Pathology, Mahatma Gandhi Medical College and Hospital, Jaipur *Email id of corresponding author: dkgsudha@yahoo.com Received: 11/09/2015 Revised: 12/11/2015 Accepted: 30/11/2015 ABSTRACT: Background: Carcinoma cervix is the most common genital cancer encountered in clinical practice in India. The categorization of cervical carcinoma in terms of only their morphological appearance, in Hematoxylin and Eosin stained sections, yields incomplete and often erroneous diagnosis. Recategorisation of ca cervix based on Mucin characterstics is of academic, as well as prognostic importance. The study was conducted with the objective demonstrating mucin in cervical Carcinomas, that were originally classified as squamous cell carcinomas, and to reclassify and modify their histological diagnosis.methods: The study was conducted by staining sections from cervical biopsies of 551 patients that were clinically suspected and/or diagnosed as having carcinoma cervix, and subsequently confirmed histopathologically by Hematoxylin and Eosin staining, received at the Histopathology section of Department of Pathology, Mahatma Gandhi Medical College, Jaipur. PAS and Alcain-blue Mucin stains were used. Results: Majority of these patients(62%), were in the age group of 41 to 60 years. 80% of the patients came with the complaints of bleeding and discharge per vaginum (PV). 10.91% mucin secreating neoplasms were falsely classified as squamous cell carcinoma by Heamtoxylin and Eosin method.conclusions: Mucin histochemistry should be carried out routinely in all the cases of carcinoma cervix. Key Words: CA Cervix, Adenosquamous carcinoma, Mucin stains INTRODUCTION: Carcinoma cervix is the most common genital cancer encountered in clinical practice in India (80%). The death toll is around 70,000 cases every year (1). India accounts for about 20% of cervical cancer cases reported from the world (2). The high prevalence and mortality, therefore, makes the study of ca cervix essential. No form of cancer better documented the remarkable effects of prevention, early diagnosis and curative therapy on mortality and morbidity rate Page 82

than carcinoma cervix, because carcinoma cervix follows a progressive course from dysplasia to carcinoma in situ and eventually, to invasive carcinoma (3). Worldwide, high risk type HPV-16 and 18 contribute over 70% of all cervical cancer cases. Most common in India are also type 16 and 18 (4). Most cervical carcinoma arises at the squamocolumnar junction of the cervix, which represents the labile transformation zone. Invasive cervical carcinoma has been divided into various categories based on their histological appearance and staining characteristics (5). Squamous cell carcinomas account for about 80% of cancers of the uterine cervix, and the majority of the remainder are adenocarcinomas (6). The categorization of cervical carcinoma in terms of only their morphological appearance, in Hematoxylin and Eosin stained sections, yields incomplete and often erroneous diagnosis. In reality, only about 70% of cervical carcinomas are purely squamous. Many Mucin Secreting cancers escape detection unless a mucin stain (PAS and Alcian Blue) is applied (5,7,8). It has been shown in various studies that adenosquamous carcinomas often pursue an aggressive course and are associated with worse prognosis, than the purely adeno or squamous counterparts, because most of them are poorly differentiated (9).Also, these covert mucus secreting tumors occur with undue frequency in women less than 40 years, and accounts to significant extent of poor prognosis in young patients, who present with rapidly metastasizing tumors and respond poorly to conventional treatment (10,11,12,13). Hence, recategorisation of carcinoma cervix based on Mucin characterstics is of academic, as well as prognostic importance. The study was conducted with the objective demonstrating mucin in cervical Carcinomas, that were originally classified as squamous cell carcinomas, and to reclassify and modify their histological diagnosis. MATERIAL & METHODS The study was conducted by staining sections from cervical biopsies of 551 patients that were clinically suspected and/or diagnosed as having carcinoma cervix of epithelial origin, and subsequently confirmed histopathologically by Hematoxylin and Eosin staining, received at the Histopathology section of Department of Pathology, Mahatma Gandhi Medical College, Jaipur from Feb 2014 to Jan 2015. Consent was taken from the ethics committee of the institute and the patients participating in the study. The material consisted of two main groups of specimens: 1) Control group :- A) Sections from kidney - Periodic Acid Schiff's method. B) Sections from colon - Orcein Alcian Blue [OR/AB (ph2.5)] 2) Cervical biopsies:- 3 paraffin sections, 4µi thick, stained with- (A) Hematoxylin and Eosin (B) Periodic Acid and Schiff: for demonstration of neutral mucin. (C) Orcein-Alcian Blue (ph 2.5): for demonstration of acidic mucin. The data collected were analysed using SPSS software. RESULTS In the present study, a total of 55 cases were studied. Majority of these patients(62%), were in the age group of 41 to 60 years. 29% of the Page 83

patients were less than 41 years of age, and 9% were more than 61 years old. 80% of the patients came with the complaints of bleeding and discharge per vaginum (PV). Remaining either had isolated discharge or bleeding PV, with minor complains of backache, weakness and pain abdomen. The classification of cervical carcinomas based on Hematoxylin and eosin staining and reclassification with mucin stains is given in Table 1. It shows that around 10.91% mucin secreating neoplasms were falsely classified as squamous cell carcinoma by Heamtoxylin and Eosin method. The histopathological categorization of the 55 cases of carcinoma cervix, before and after mucin histochemistry is shown in Table No. 2. Without the Mucin stain, out of 55 cases, 51 cases were squamous cell carcinoma, 03 cases were adenocarcionoma and 1 case was adenosquamous carcinoma. With the mucin stain, out of 55 cases, 45 cases (81.82%) were classified as squamous cell carcinoma, 03 cases (05.45%) were classified as adenocarcinoma and 07 cases (12.72%) were classified as adenosquamous carcinoma of cervix. There is significant increase in the number of adenosquamous carcinoma with mucin stain. DISCUSSION Mucin containing carcinomas are aggressive tumors with high prevalence of lymph node metastasis (9,10), are radioresistant (12,13) and carry poor prognosis. Considering all these factors, it becomes essential to recognize them. This can help in planning the management of patients, as studies have shown improved survival rates when mucin containing tumors are treated with combined radiotherapy and surgery, instead of conventional treatment with radiations only (12). Buckley et al (1989) stated that mucin secreting cervical, carcinomas occur with greater frequency in women under the age of 40 year (5). In the present study, the mean age of the patients with cervical carcinoma was found to be 49.02 years, and those of mucin secreting cervical carcinomas was 42.84 years. In the present study, 80% of the cases presented with bleeding (postmenopausal bleeding/post coital bleeding/irregular bleeding) and foul smelling vaginal discharge which is well correlated with the study of Howkins and Boume (1971) (14) In present study total 55 cases clinically diagnosed and /or suspected of having carcinoma cervix were evaluated histologically and histochemically. The histological case distribution was observed as squamous cell carcinoma - 92.73%, adenocarcinorna - 05.45% and adenosquamous 01.82%. Histochemically they were typed as squamous cell carcinoma - 81.82%, adenocarcinoma - 05.45% and adenosquarnous 12.72% In the present study squamous cell carcinomas form the major proportion of cases number being 51 (92.73%). Out of 55 cases adenocarcinoma was second in the list accounting to 3 in number (05.45%) and adenosquamous was the last common out of these three categories, the number being 1(1.82%). These carcinomas were further sub classified into well, moderate and poorly differentiated categories. Moderately differentiated squamous cell carcinoma were 48 cases (94.12%) which forms the most common category of carcinoma cervix. 100% cases of adenocarcinoma and adenosquamous demonstrated mucin. Only 6 cases of squamous cell carcinoma demonstrated mucin. Page 84

As a result of mucin staining, original classification was revised in 6 cases (10.91%) of Squamous cell carcinoma. All the 6 cases were of moderately differentiated squamous cell carcinomas which were reclassified as adenosquamous (mixed) carcinoma. Frequency of squamous cell carcinoma in this study (94.731/0) was relatively higher than other studies and this could possibly be because of relative low proportion of adenocarcinomas observed in the present study (15). Recent reports have shown an increase in the proportion of glandular neoplasms, but whether this increase is absolute or relative is undetermined (16). Benda (1985) 7 documented maximum percentage (33%) of cases which required reclassification followed by Buckely (15.6%). In present study, reclassification was required in 10.91% cases, which is in close approximation to the percentage reported by Buckely et al (1988) (10). CONCLUSION Mucin histochemistry should be carried out routinely in all the cases of carcinoma cervix as Hematoxylin and Eosin staining is not sufficient.this aids in the early detection of previously unrecognized mucin secreting adenocarcinoma and adenosquamous carcinoma, which pursue a more aggressive clinical course, and poorer prognosis than non mucin producing squamous cell carcinoma. REFERENCES 1) Padubidri VG, Daftary SN. Shaw's text book of Gynaecology. Elsevier. 16 th edition. 2015 2) Guidelines for cervical cancer screening. Government of India and WHO collaborative programme. Accessed on Jan 23, 2012. Available from: http://www.whoindia.org/linkfiles/cancer_reso urce_guidelines_for_ccsp.pdf 3) Mathur SK, Marwaha N, Arora R, Gupta S, Arora B. Significance of mucin secretion in carcinoma of uterine cervix. Indian Journal of Pathology & microbiology.2002; 45 (3): 261-264 4) World Health Organisation. HPV IARC monograph summary. Llancet oncol. 2005; 6:204 5) Buckley CH, Fox H. Carcinoma of the cervix: Recent advances in histopathology, Churchill Livingstone. 1989. 14: 63-76 6) Gonzalez B, Green. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix. Int J Cancer. 2007. 120(4): 885-91 7) Benda JA, Platz CE, Buchsnawm H, Lfshitz S. Mucin production in defining mixed carcinoma of uterine cervix: a clinico-pathologic study: International Journal of Gynaecological Pathology. 1985 (4): 314-27 8) Yajma A, Fakunda M, Noda K. Histopathological findings concerning the morphogenesis of mixed carcinoma of the uterine cervix: Gynaecologic Oncology. 1984. (18): 157-164 9) Ireland D, Cole S, Kely P, Monaghan JM. Mucin production in intraepithelial neoplasia and in stage lb carcinoma of 'cervix with pelvic lymph node metastasis: British Journal of Obstetrics and Gynaecology.1987. (94): 467-72 10) Buckley CH, Beards CS, Fox H. Pathological prognostic indicator in cervical cancer with reference to patients under 40 years of age: British Journal of Obstetrics and Gynaecology.1988. (95): 47-56 11) Sàigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL. Prognostic factors in adenocarcinorna of the cervix Cancer. 1986.57: 1584-1593 12) Glucksman A, Cherry CP. Incidence, histology and response to radiation of mixed Page 85

carcinomas of uterine cervix: Cancer. 1956.9: 971-979 13) Swan DS, Roddick JW, A clinical pathological correlation of cell type classification for cervical cancer: 'American Journal of Obstetrics and Gynaecology.1973. 116; 666-670 14) Howkins J, Bourne G. Textbook of gynaecology, 7th edition, ELBS and Churchill Livingstone, Edinburgh and London.1971. 15) Abell MR and Gosling JR : Gland cell carcinoma of cervix. Am J. Obstet Gynac. 1962.83: 729-735 16) Davis JR. Moon LB: Increased incidence of adenocarcinoma of the uterine.cervix: Obstet Gynecol. 1975 (45): 79-83 TABLE NO. 1 Classification by Hematoxylin and Eosin And with Mucin stains. Diagnosis Hematoxylin and Eosin Mucin stain Squamous cell carcinoma 51 (92.73%) 45 (81.82%) Adenocarcinoma 3 (05.45%) 3 (05.45%) Adenosqamous 1 (01.82%) 1 (01.82%) Squamous cell carcinoma with mucin secretion 6 (10.91%) TABLE NO. 2: Histopathological categorization before and after mucin histochemistry Diagnosis Before mucin stain After mucin stain No. of cases Percentage No. of cases Percentage Squamous cell carcinoma 51 92.73% 45 81.82% Well differentiated 00 00.00% 00 00.00% Moderately differentiated 48 94.12% 42 93.33% Poorly differentiated 03 05.88% 03 06.67% Adenocarcinoma 03 05.45% 03 05.45% Well differentiated 00 00.00% 00 00.00% Moderately differentiated 02 66.67% 02 66.67% Poorly differentiated 01 33.33% 01 33.33% Adenosquamous 01 01.82% 07 12.72% Page 86